Prognostic role of factor XIII gene variants in nonhealing venous leg ulcers.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Vascular Surgery

• Publication date

  2006-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JVS.2006.06.006PMID 16945500
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Factor XIII Deficiency Causes Cardiac Rupture, Impairs Wound Healing, and Aggravates Cardiac Remodeling in Mice With Myocardial Infarction

  2006cited by this paper
• Factor XIII (FXIII) and angiogenesis

  2006cited by this paper
• Risk factors for delayed healing and recurrence of chronic venous leg ulcers--an analysis of 1324 legs.

  2005cited by this paper
• Venous ulcer: epidemiology, physiopathology, diagnosis and treatment

  2005cited by this paper
• Factor XIII Contrasts the Effects of Metalloproteinases in Human Dermal Fibroblast Cultured Cells

  2004cited by this paper
• Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension

  2004cited by this paper
• Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction.

  2003cited by this paper
• Extracellular matrix remodelling: the role of matrix metalloproteinases

  2003cited by this paper
• Factor XIII subunit A as an intracellular transglutaminase

  2003cited by this paper
• Activated macrophages for treating skin ulceration: gene expression in human monocytes after hypo‐osmotic shock

  2002cited by this paper
• Wound healing

  2002cited by this paper
• Treatment of nonhealing leg ulcers with fibrin-stabilizing factor XIII: a case report.

  2002cited by this paper
• A common mutation in the gene for coagulation factor XIII‐A (VAL34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases

  2001cited by this paper
• Effect of Factor XIII Val34Leu on α2-antiplasmin Incorporation into Fibrin

  2000cited by this paper
• Factor XIII-mediated inhibition of fibrinolysis and venous leg ulcers.

  2000cited by this paper
• Genotype/phenotype correlations for coagulation factor XIII: specific normal polymorphisms are associated with high or low factor XIII specific activity.

  1999cited by this paper
• The Leu564 Factor XIIIA Variant Results in Significantly Lower Plasma Factor XIII Levels than the Pro564 Variant

  1999cited by this paper
• Prevalence of Three Common Polymorphisms in the A-subunit Gene of Factor XIII in Patients with Coronary Artery Disease

  1999cited by this paper
• Soluble Vascular Cell Adhesion Molecule-1 (VCAM-1) as Potential Marker of Atherosclerosis

  1999cited by this paper
• A Common Coding Polymorphism in the FXIII A-subunit Gene (FXIIIVAL34LEU) Affects Cross-linking Activity

  1998cited by this paper
• The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity.

  1998cited by this paper
• Chronic wound healing.

  1997cited by this paper
• Factor XIII in Chronic Inflammatory Bowel Diseases

  1996cited by this paper
• Factor XIII in Ulcerative Leg Disease: Background and Preliminary Clinical Results

  1996cited by this paper
• Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII.

  1994cited by this paper
• Factor XIII-deficiency in the blood of venous leg ulcer patients.

  1991cited by this paper
• Factor XIII of blood coagulation inhibits the oxidative phagocyte metabolism and suppresses the immune response in vivo.

  1991cited by this paper

• Glycocalyx disruption, endothelial dysfunction and vascular remodeling as underlying mechanisms and treatment targets of chronic venous disease.

  2024cites this paper
• LINE-1 global DNA methylation, iron homeostasis genes, sex and age in sudden sensorineural hearing loss (SSNHL)

  2023cites this paper
• Pathophysiology and Conservative Treatment of Venous Ulcers: A Review

  2022cites this paper
• Allogeneic ABCB5+ Mesenchymal Stem Cells for Treatment-Refractory Chronic Venous Ulcers: A Phase I/IIa Clinical Trial

  2021cites this paper
• Epidemiology and Genetics of Venous Thromboembolism and Chronic Venous Disease

  2021cites this paper
• Cis-Segregation of c.1171C>T Stop Codon (p.R391*) in SERPINC1 Gene and c.1691G>A Transition (p.R506Q) in F5 Gene and Selected GWAS Multilocus Approach in Inherited Thrombophilia

  2021cites this paper
• Genetics and Epigenetics of One-Carbon Metabolism Pathway in Autism Spectrum Disorder: A Sex-Specific Brain Epigenome?

  2021cites this paper
• Mechanisms of Lower Extremity Vein Dysfunction in Chronic Venous Disease and Implications in Management of Varicose Veins.

  2021cites this paper
• Pending questions in venous ulcers management. Report from a Symposium of the World Union of Wound Healing Societies International Congress

  2020cites this paper
• COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-Chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?

  2020cites this paper
• The profile of patients with venous leg ulcers: A systematic review and global perspective.

  2020cites this paper
• Sex/Gender-Specific Imbalance in CVD: Could Physical Activity Help to Improve Clinical Outcome Targeting CVD Molecular Mechanisms in Women?

  2020cites this paper
• Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19

  2020cites this paper
• Maternal Haplotypes in DHFR Promoter and MTHFR Gene in Tuning Childhood Acute Lymphoblastic Leukemia Onset-Latency: Genetic/Epigenetic Mother/Child Dyad Study (GEMCDS)

  2019cites this paper
• Genetic biases related to chronic venous ulceration.

  2019cites this paper
• “Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era

  2019cites this paper
• Pathophysiology of Chronic Venous Disease and Venous Ulcers.

  2018cites this paper
• Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases

  2018cites this paper
• F13A1 Gene Variant (V34L) and Residual Circulating FXIIIA Levels Predict Short- and Long-Term Mortality in Acute Myocardial Infarction after Coronary Angioplasty

  2018cites this paper
• Inherited genetic predispositions in F13A1 and F13B genes predict abdominal adhesion formation: identification of gender prognostic indicators

  2018cites this paper
• Factor XIII Subunit A in the Skin: Applications in Diagnosis and Treatment

  2017cites this paper
• The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study

  2016cites this paper
• Генетические основы хронических заболеваний вен нижних конечностей: обзор современных представлений

  2016cites this paper
• PROGNOSTIC FACTORS IN VENOUS ULCER HEALING

  2016cites this paper
• Coagulation Factor XIIIA (F13A1): Novel Perspectives in Treatment and Pharmacogenetics.

  2016cites this paper
• The increased killing of biofilms in vitro by combining topical silver dressings with topical negative pressure in chronic wounds

  2016cites this paper
• Pathogenesis of venous ulcer.

  2015influential citation
• Venous leg ulceration pathophysiology and evidence based treatment

  2015cites this paper
• Chronic Venous Insufficiency and Venous Ulcers: Pathophysiology

  2015cites this paper
• Factor XIIIA-V34L and factor XIIIB-H95R in venous thromboembolism in central Iran: protective and neutral

  2014cites this paper
• Haemostaseome-associated SNPs: has the thrombotic phenotype a greater influence than ethnicity?

  2014cites this paper
• Omics profiles in chronic venous ulcer wound fluid: innovative applications for translational medicine

  2014cites this paper
• Management of venous leg ulcers: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum Endorsed by the American College of Phlebology and the Union Internationale de Phlébologie

  2014cites this paper
• Pathophysiology of chronic venous disease.

  2014cites this paper
• Clinical practice guidelines of the Society for Vascular Surgery (SVS) and the American Venous Forum (AVF)--Management of venous leg ulcers. Introduction.

  2014cites this paper
• Current aspects in Chronic Venous Disease

  2014cites this paper
• Review paper Prognostic factors for delayed healing of venous leg ulcers

  2014cites this paper
• Benefits of micronized purified flavonoid fraction PAGE 95 in the reduction of symptoms after operation for hemorrhoidal disease

  2014cites this paper
• Management of venous leg ulcers: clinical practice guidelines of the Society for Vascular Surgery ® and the American Venous Forum.

  2014cites this paper
• Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

  2013cites this paper
• Molecular Genetics of Primary Varicose Vein Disease

  2013cites this paper
• Urinary hemosiderin: role in evaluation of chronic venous insufficiency

  2012cites this paper
• A review of familial, genetic, and congenital aspects of primary varicose vein disease.

  2012cites this paper
• Factor XIII: a coagulation factor with multiple plasmatic and cellular functions.

  2011influential citation
• Review: Interplay of Iron Metallobiology, Metalloproteinases, and FXIII, and Role of Their Gene Variants in Venous Leg Ulcer

  2010cites this paper
• Genetic risk factors of chronic venous leg ulceration: Can molecular screening aid in the prevention of chronic venous insufficiency complications?

  2010cites this paper
• Factors influencing the development of severe venous changes following deep vein thrombosis

  2010cites this paper
• Chronic Venous Disorders

  2010cites this paper
• Role of PTEN in the Tumor Microenvironment

  2009cites this paper
• DNA-array of gene variants in venous leg ulcers: detection of prognostic indicators.

  2009cites this paper
• Mechanisms of varicose vein formation: valve dysfunction and wall dilation

  2008cites this paper
• Genetics of venous leg ulcer: an indication to priority of varicose veins treatment?

  2008cites this paper
• Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants: Effects on Survival in Myocardial Infarction Patients

  2007cites this paper
• Clinical implications of gene polymorphisms in venous leg ulcer: A model in tissue injury and reparative process

  2007cites this paper
• The Genetic Base of Chronic Venous Disease : a Review of Modern Concepts

  year unknowncites this paper